Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Blesa

Showing results (131-140 of 158) with videos related to

Pageof 16
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 3, 2017
Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's diseaseMaría Carmona-Iragui, Mircea Balasa, Bessy Benejam, et al.
EMBO Molecular Medicine|March 5, 2016
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markersMarc Suárez-Calvet, Gernot Kleinberger, Miguel Ángel Araque Caballero, et al.
Brain : a Journal of Neurology|November 28, 2017
Synaptic phosphorylated α-synuclein in dementia with Lewy bodiesMartí Colom-Cadena, Jordi Pegueroles, Abigail G Herrmann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 6, 2023
Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndromeMateus Rozalem Aranha, Maria Florencia Iulita, Victor Montal, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 9, 2021
Use of plasma biomarkers for AT(N) classification of neurodegenerative dementiasDaniel Alcolea, Constance Delaby, Laia Muñoz, et al.
Lancet (London, England)|June 29, 2020
Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional studyJuan Fortea, Eduard Vilaplana, Maria Carmona-Iragui, et al.
Human Molecular Genetics|September 24, 2013
Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementiaOriol Dols-Icardo, Alberto García-Redondo, Ricard Rojas-García, et al.
Neurobiology of Aging|December 18, 2015
Assessing the role of TUBA4A gene in frontotemporal degenerationOriol Dols-Icardo, Oriol Iborra, Jessica Valdivia, et al.
Ebiomedicine|April 1, 2023
Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort studyLaia Montoliu-Gaya, Daniel Alcolea, Nicholas J Ashton, et al.
Journal of Alzheimer'S Disease : JAD|January 29, 2019
Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment)Barry Reisberg, Carol Torossian, Melanie B Shulman, et al.
Pageof 16

Showing results (131-140 of 158) with videos related to

Sort By:
Pageof 16
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 3, 2017
Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's diseaseMaría Carmona-Iragui, Mircea Balasa, Bessy Benejam, et al.
EMBO Molecular Medicine|March 5, 2016
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markersMarc Suárez-Calvet, Gernot Kleinberger, Miguel Ángel Araque Caballero, et al.
Brain : a Journal of Neurology|November 28, 2017
Synaptic phosphorylated α-synuclein in dementia with Lewy bodiesMartí Colom-Cadena, Jordi Pegueroles, Abigail G Herrmann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 6, 2023
Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndromeMateus Rozalem Aranha, Maria Florencia Iulita, Victor Montal, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 9, 2021
Use of plasma biomarkers for AT(N) classification of neurodegenerative dementiasDaniel Alcolea, Constance Delaby, Laia Muñoz, et al.
Lancet (London, England)|June 29, 2020
Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional studyJuan Fortea, Eduard Vilaplana, Maria Carmona-Iragui, et al.
Human Molecular Genetics|September 24, 2013
Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementiaOriol Dols-Icardo, Alberto García-Redondo, Ricard Rojas-García, et al.
Neurobiology of Aging|December 18, 2015
Assessing the role of TUBA4A gene in frontotemporal degenerationOriol Dols-Icardo, Oriol Iborra, Jessica Valdivia, et al.
Ebiomedicine|April 1, 2023
Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort studyLaia Montoliu-Gaya, Daniel Alcolea, Nicholas J Ashton, et al.
Journal of Alzheimer'S Disease : JAD|January 29, 2019
Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment)Barry Reisberg, Carol Torossian, Melanie B Shulman, et al.
Pageof 16